Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.05
-0.56 (-12.15%)
At close: Aug 15, 2025, 11:03 AM
Vivos Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.24M | -11.14M | -12.57M | -12.04M | -15.64M | -13.58M | -15.41M | -18.75M | -20.03M | -23.84M | -25.15M | -25.17M | -22.4M | -20.29M | -19.14M | -15.5M | -12.88M |
Depreciation & Amortization | 612K | 581K | 586K | 589K | 592K | 621K | 641K | 668K | 803K | 669K | 668.23K | 684.73K | 596.5K | 733K | 742.1K | 728.52K | 714.39K |
Stock-Based Compensation | 786K | 762K | 857K | 904K | 1.09M | 1.11M | 1.73M | 1.89M | 2.09M | 2.4M | 2.08M | 2.85M | 2.83M | 2.66M | 3.02M | 2.34M | 2.25M |
Other Working Capital | 185K | 957K | 1.59M | 1.03M | 1.97M | 1.21M | 2.04M | 334K | 820K | 474K | -2.08M | -2M | -752.47K | -507K | 680.12K | 1.27M | 234.66K |
Other Non-Cash Items | -2.58M | -2.02M | -1.92M | -1.06M | 5.91M | 2.8M | 2.56M | 4.56M | -2.02M | -518K | -401.48K | -655.18K | -1.07M | -9K | 3.49M | 3.5M | 3.75M |
Deferred Income Tax | n/a | n/a | 192K | 192K | -5.75M | -5.75M | -5.94M | -5.94M | n/a | n/a | 911.28K | 911.28K | 911.28K | 1.14M | 231.72K | 231.72K | 231.72K |
Change in Working Capital | -1.12M | -319K | 906K | 862K | 3.43M | 2.86M | 4.23M | 2.34M | 2.12M | 1.71M | 1.18M | 2.46M | 1.17M | 28K | -3.57M | -3.09M | -3.18M |
Operating Cash Flow | -13.97M | -12.69M | -12.5M | -11.11M | -10.92M | -11.95M | -12.2M | -15.24M | -17.04M | -19.59M | -20.71M | -18.93M | -17.96M | -15.73M | -15.23M | -11.8M | -9.1M |
Capital Expenditures | -14K | -165K | -165K | -530K | -715K | -803K | -838K | -784K | -1.04M | -924K | -1.11M | -1.45M | -2.25M | -2.4M | -2.11M | -1.68M | -376.75K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -225K | -225K | -225K | -225K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -690K | -719K | -1.36M | -954K | -954K | -853K | -50K | -50K | -50K | -120K | -119.7K | -111.21K | -332K | -473.7K | -594.26K | -602.75K | -381.95K |
Investing Cash Flow | -539K | -568K | -568K | -530K | -715K | -853K | -888K | -834K | -1.09M | -924K | -1.11M | -1.44M | -2.47M | -2.61M | -2.32M | -1.9M | -376.75K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | -25.07K | -25.07K | 1.24M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5M | n/a | n/a | n/a | -3.5M | -2M | -2M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 10.74M | 14.38M | 14.39M | 10.6M | 3.2M | -1.08M | -645K | -645K | -645K | n/a | -434 | -934 | 25.37M | 25.37M | 25.1M | 25.05M | -320.14K |
Financial Cash Flow | 14.24M | 17.88M | 18.39M | 14.6M | 7.2M | 10.92M | 7.36M | 7.36M | 7.36M | n/a | -434 | -1.17M | 24.19M | 24.17M | 44.54M | 47.48M | 23.43M |
Net Cash Flow | -269K | 4.62M | 5.32M | 2.96M | -4.43M | -1.88M | -5.73M | -8.72M | -10.78M | -20.51M | -21.82M | -21.54M | 3.77M | 5.82M | 26.98M | 33.78M | 13.95M |
Free Cash Flow | -13.98M | -12.86M | -12.66M | -11.64M | -11.64M | -12.75M | -13.04M | -16.02M | -18.09M | -20.51M | -21.82M | -20.37M | -20.21M | -18.13M | -17.34M | -13.48M | -9.48M |